About International Journal of Toxicology

The Official Journal of ACT

International Journal of Toxicology (IJT) publishes peer-reviewed, multidisciplinary articles and incisive reviews on contemporary issues in toxicology, as well as safety assessment, novel approaches to toxicological testing, mechanisms of toxicity, biomarkers, and risk assessment.

IJT serves as a forum for articles that promote basic toxicology research or facilitate and improve toxicology practice.

The journal offers six annual issues, with three supplemental issues each year devoted to contributions from the Cosmetic Ingredient Review Expert Panel. The official journal of the American College of Toxicology, IJT serves academic, industry, and regulatory toxicologists, as well as toxicology consultants.

International Journal of Toxicology is a member of the Committee on Publication Ethics (COPE).

IJT and SAGE Publishing are committed to diversity, equity, and inclusion in publishing and encourage submissions from a diverse range of authors from all countries and backgrounds.

ACT Member Access

ACT members receive full access to IJT as a member benefit. To receive an electronic alert of the IJT table of contents, sign up at SAGE Contents Alert.

Public Access

IJT articles are available via SAGE Publishing, as well as PubMed.

IJT Editorial Board

Editors
Editor-in-Chief

Mary Beth Genter, PhD, DABT, ATS | Email
University of Cincinnati, Cincinnati, OH USA

Associate Editors

Marion F. Ehrich, PhD, ATS, DABT
VA-MD College Veterinary Medicine, Blacksburg, VA USA

Donald G. Stump, PhD, DABT
Charles River, Ashland, OH USA

Book Review Editor

Robert Kapp Jr., PhD, ATS, FRSB, ERT
BioTox, Stafford Township, NJ USA

Editors Emeriti

Mildred S. Christian, PhD, Founding Editor
Robert M. Diener, DVM
Harihara M. Mehendale, PhD

Editorial Board Members
  • Krishna Allamneni, DVM, PhD, DABT
    Turning Point Therapeutics
  • Shana Azri-Meehan, PhD, DABT
    Johnson Matthey
  • Ted Baird, PhD
  • Lisa Beilke, MSPH, PhD, DABT, ERT
    Toxicology Solutions, Inc.
  • Bruce Bernard, PhD
    SRA Consulting, Inc.
  • Susan Borghoff, PhD, DABT
    ToxStrategies, Inc.
  • William Brock, PhD, DABT, ATS
    Brock Scientific Consulting, LLC
  • Alan Brown, PhD, DABT
    Novartis Institutes for Biomedical Research
  • Lorrene Buckley, PhD, DABT, ATS
    Eli Lilly and Company
  • John Budny, PhD
    PharmaCal, Ltd.
  • Gary Burleson, PhD
    Burleson Research Technologies, Inc.
  • Florence Burleson, PhD
    Burleson Research Technologies, Inc.
  • Leigh Ann Burns Naas, PhD, DABT, ATS, ERT
    Magnolia Toxicology Consulting, LLC
  • Erica Carroll, DVM, PhD, DACVP, DABT, FIATP
    Covance by Labcorp
  • Charleata Carter, PhD, ERT
    Carter Consulting-Alcon Regulatory Toxicologist
  • Scott Coleman, PhD
    Acceleron Pharma
  • David Compton, PhD, DABT
    PTC Therapeutics
  • Mary Ellen Cosenza, PhD, DABT, RAC, ATS
    MEC Regulatory & Toxicology Consulting, LLC
  • Matthew Dieter, PhD, DABT
    Eli Lilly and Company
  • Marion Ehrich, PhD, ATS, DABT
    VA-MD Col Veterinary Medicine
  • Sandy Eldridge, PhD, DABT
    National Cancer Institute
  • Shayne Gad, PhD, DABT
    Gad Consulting Services
  • Mary Beth Genter, PhD, DABT, ATS
    University of Cincinnati
  • Hanan Ghantous, PhD, DABT
    US FDA
  • Robin Guy, MS, DABT, RQAP-GLP
    Robin Guy Consulting, LLC
  • Bert Haenen, PhD, ERT
    Janssen Pharmaceutical Companies
  • Jerry Hardisty, DVM
    EPL, Inc.
  • Stephen Harris, PhD, ATS, FRSB
    Stephen B. Harris Group
  • Kenneth Hastings, DrPH, DABT, ATS
    Hastings Toxicology Consulting, LLC
  • Alan Hoberman, PhD, DABT, ATS
    Charles River
  • David Hobson, PhD, DABT
    LoneStar PharmTox LLC
  • Debie Hoivik, PhD, DABT
    Akebia Therapeutics
  • Heidi Hsieh, PhD
    Covance Inc.
  • Robert Kapp, Jr., PhD, ATS, FRSB, ERT
    BioTox
  • Elaine Knight, PhD
    National Cancer Institute
  • Stephen Montgomery, PhD
    Regulatory and Toxicology Consultants, LLC
  • P. Balakrishna Murthy, PhD, DSc
    Consultant Toxicologist
  • Kenneth Olivier, Jr., PhD
  • Madhav Paranjpe, DVM, MS, PhD, DACVP, FIATP
    Charles River Laboratories
  • Gunda Reddy, PhD, DABT, ATS
  • Robert Roy, PhD, DABT, ATS
    3M
  • Alan Stokes, PhD, DABT
    GlaxoSmithKline
  • Donald Stump, PhD, DABT
    Charles River
  • Tao Wang, MD, PhD, DABT
    Coherus BioSciences
  • Adam Woolley, DABT, FRCPath, ERT, ATS
    ForthTox, Ltd.
  • David Woolley, PhD, DABT, BSc, MRSB, CBiol, ERT
    ForthTox, Ltd.
Join Today!
Become an ACT member

and receive full access to IJT as a member benefit! We invite you to join today.

TOP